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Nonalcoholic Fatty Liver Disease
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Otterbein University, Westerville, Ohio
Introduction
Nonalcoholic fatty liver disease (NAFLD) is the most
common chronic liver disease in the United States (McCance,
Huether, Brashers, & Rote, 2014, p. 1461). Historically, NAFLD
primarily affected adults; however, Berardis and Sokal (2014)
identified NAFLD has also become the most common cause of
chronic liver disease among children and adolescents in
Western countries (p. 131). In association with rising rates of
childhood obesity, the prevalence of children with NAFLD has
more than doubled in the last two decades with the most recent
estimate for NAFLD at 9.6% of the general pediatric population
(Kohli et al., 2016, p. 9). While the disease process itself does
not cause significant illness directly, children and adolescents
with NAFLD are at much higher risk for serious chronic
illnesses long term.

Risk Factors

Underlying Pathophysiology
In its healthy state, the liver is able to synthesize, catabolize,
and store triglycerides and fatty acids (FFA) to be used as energy
by the rest of the body. In moderation, the liver is able to break
down triglycerides into glycerol and FFA and store any unneeded
supplies until they are needed at a later time. However, if the liver
is unable to process excess quantities of these molecules, the
surplus of triglycerides and/or FFAs are stored in hepatocytes as
fat. The organelles in these cells become disrupted as large
vacuoles of fat form within the cell membrane (McCance et al.,
2014).
Causes of hepatic triglyceride accumulation include: increased
delivery of free fatty acids to the liver, increased lipogenesis, and
impaired fatty acid metabolism in hepatocytes (Berardis & Sokol,
2014, p. 132). Increased delivery of FFAs may be the result of
increased dietary intake or the release of FFAs from adipose cells.

The primary risk factor in the development of NAFLD is
obesity, specifically increased levels of adipose tissue. Other
risk factors include elevated triglyceride levels, elevated
cholesterol levels, and insulin-resistance either with or without
type 2 diabetes mellitus.

Significance of Pathophysiology

Implications for Nursing Care
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As NAFLD is often asymptomatic, it can be present for years before it is detected. This
chronic, underlying condition has the potential to progress to serious, life-threatening
illnesses. If not addressed. NAFLD has the potential to progress to the following conditions:
Nonalcoholic Steatohepatitis
Nonalcoholic steatohepatits (NASH) occurs when hepatocytes become injured by stored
fats and inflammatory processes take over leading to the recruitment cells in the innate
immune system including: Toll-like receptors (TLRs), Kupffer cells (KCs), lymphocytes and
neutrophils and possibly inflammasome (Farrell, van Rooyen, Gan, & Chitturi, 2012, p. 149).
The effects of NASH are destruction of liver cells with possible progression to fibrosis which
leads to decreased liver function.
Cirrhosis
If the inflammation and fibrosis continue, damage in the liver can progress to cirrhosis.
Cirrhosis occurs when fibrous tissue replaces damaged hepatocytes, leading to further
decrease in liver function. Cirrhosis is the twelfth leading cause of death in the United States
and can lead to portal hypertension and jaundice (McCance et al., 2014, p. 1460).
Liver Cancer
Further damage to the liver can result in the formation of malignant neoplasms or
hepatocellular carcinoma. Although cirrhosis is not a direct cause for all cases of liver
cancer, it is a significant and preventable risk factor that leads to a potentially-fatal
condition. The American Cancer Society estimates ~42,000 individuals will be diagnosed
with primary liver cancer in 2018 and of those individuals, ~30,000 will die from this
illness (American Cancer Society, 2018).

Because there is no treatment for NAFLD, education plays a key role in the
prevention and management of NAFLD in children, adolescents, and adults. Both
registered nurses (RN) and advanced practice nurses (APN) are valuable resources to
provide education to patients and families to prevent further damage initiated by
NAFLD. Important education topics include education about dietary changes,
promotion of physical activity, and the importance of screening tests and imaging
procedures.
While some studies have examined specific nutrients to determine if certain foods
place individuals at higher risk for NAFLD, Anderson et al. (2016) found that overall
higher energy intake in childhood and early adolescents is associated with greater risk
for NAFLD while the types of macronutrients are less important (p. 988). With this in
mind, RNs and APNs should focus on moderation rather than restriction when
providing education about healthy diets to their patients.
Anderson et al. (2015) found increased exercise in in late childhood and lower fat
mass in adolescence is linked to lower risk of ultrasound scan fatty liver and liver
enzymes indicative of NAFLD (p. 116). In day-to-day clinical practice, RNs and APNs
have valuable patient contact and are in pivotal roles to spend time educating their
patients about lifestyle interventions including the importance of physical activity. Even
if not the primary purpose of the contact, nurses should include questions about
physical activity in their assessments. These questions allow nurses to determine
where gaps exist and education about the importance of exercise may be beneficial in
the prevention of NAFLD and many other chronic conditions.
APNs should also be knowledgeable about basic screening, laboratory, and imaging
procedures related to widespread metabolic conditions including NAFLD. By
incorporating regular blood testing, including lipid profiles, glucose tests, and hepatic
function panels in their assessments, APNs may be able to identify high-risk individuals
and target specific interventions before the disease progresses. In addition, APNs
should know that liver scans have proven reliable to assess the amount of liver damage
in individuals; however, Anderson et al. (2016) found liver scans have proven more
useful in the detection of moderate-severe hepatic steatosis and are less able to
determine mild fat infiltration (p. 115). This may lead to further progression of the
disease if providers rely on this procedure for early detection. Liver biopsy has been
identified as the “gold standard” to diagnose NAFLD (Berardis & Sokal, 2014, p. 134);
however, it does impact individuals more significantly than less invasive procedures.
Due to the risks for complications, biopsies should only be considered when absolutely
necessary.
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Signs & Symptoms
NAFLD is usually asymptomatic; however, certain
individuals may experience:
• Enlarged liver
• Fatigue
• Pain in the right upper abdominal quadrant (Mayo Clinic,
2018)

Changes at the Cellular Level
NAFLD develops when liver cells become infiltrated with fat.
Under the microscope, these hepatocytes contain visible
amounts of fat within the cell membranes. Visible signs of
inflammation may be present also if NAFLD has begun to
progress to nonalcoholic steatohepatitis (NASH).

Figure 2. Pathophysiology of nonalcoholic fatty liver disease. From
“Mechanisms of Disease Progression in Nonalcoholic Fatty Liver
Disease” by J. Jou, S.S. Choi, & A.M. Diehl, 2008, Seminars in Liver
Disease, 28, 371.

Triglyceride accumulation occurs both in the liver as well as
elsewhere in the body and contributes to the formation of
adipocytes and adipose tissue. With increased adiposity comes a
decreased level of serum adiponectin which increases hepatic
glucogenesis and decreases skeletal muscle glucose uptake. This
increase in levels of glucose as well as decrease in level of
consumption contribute to further metabolic disruption and
additional lipogenesis. In addition to releasing FFAs, adipose
tissue also releases a number of inflammatory markers including
TNF-⍺ and IL-6 which contribute to further metabolic disruption
(McCance et al., 2014).

Figure 1. Comparison of normal and fatty liver cells. From
Nonalcoholic fatty liver disease by Mayo Clinic, 2018. Retrieved
from https://www.mayoclinic.org/diseasesconditions/nonalcoholic-fatty-liver-disease/symptomscauses/syc-20354567

Figure 3. Fatty liver. “Liver and
Biliary Disease.” (n.d.).
Retrieved July 16, 2018 from
http://www.pathguy.com/lect
ures/fatty_liver.jpg

Conclusion
Figure 4. Progression of liver damage. From Fatty liver disease by Fact Dr., 2018. Retrieved
from https://factdr.com/health-conditions/fatty-liver-disease/
Damage to the liver may also result in disease processes in other body systems. Once the
liver has become damaged, the affected individual is at risk for the following conditions:
Insulin Resistance
Increased levels of free fatty acids associated with NAFLD have been linked to the
disruption of intracellular insulin signaling, decreased tissue responses to insulin, and
alterations in insulin incretin and glucagon secretion (McCance et al., 2014, p. 739) placing
these individuals at risk for the development of type 2 diabetes mellitus and its associated
metabolic complications.
Atherosclerosis
Liver dysfunction and elevated levels of serum cholesterol levels as well as the release of
inflammatory cytokines related to chronic inflammation are associated with endothelial
damage that can lead to the formation of atherosclerotic plaques.
Portal Hypertension
Damage to the liver and its associated formation of scar tissue contribute to obstruction
and remodeling of the portal venous system; this ultimately leads to portal hypertension
and its associated complications which affect multiple body systems. Complications
include: varices, splenomegaly, hepatopulmonary syndrome, ascites, and hepatic
encephalopathy which may lead to fatal hemorrhage, thrombocytopenia, respiratory
complications, electrolyte imbalances, infection, and mental status changes (McCance et al.,
2014, p. 1452-1454)

NAFLD is an often silent disease with serious health risks. If action is not taken to
halt its pathologic processes, NAFLD may cause serious damage to the liver and other
body systems. The importance of interventions related to energy intake and physical
activity in obese children is well documented in the literature, citing the reduction of
adipose tissue and the development of lean body mass as important processes to
improve insulin sensitivity and decrease free fatty acids from entering the liver
(Anderson et al., 2016, p. 111; Anderson et. al., 2015, p. 983) and ultimately leading to
the development of NAFLD. By performing educational interventions in the form of
promoting healthy diets and increased physical activity, RNs and APNs may be able to
help children and adolescents decrease these risk factors, resulting in decreased
incidence and/or progression of NAFLD and lead to better qualities of life long term.
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